Try our Advanced Search for more refined results
Intellectual Property UK
-
April 02, 2025
UPC Won't Assess Patents That Lapsed Before 2023
The Unified Patent Court said Wednesday that it cannot assess infringement of national parts of European patents that lapsed before the court opened its doors in June 2023, ruling that jurisdiction over such disputes lies with national courts.
-
April 02, 2025
Royal Mail Database IP Claim Gets Off To Rocky Start
Royal Mail Group and the operator of an address search website argued Wednesday that software firm Codeberry Ltd. copied millions of addresses from the courier's postcode data without permission, as the High Court case opened without counsel for defendants.
-
April 02, 2025
Safestand Wins Appeal To Protect Scaffolding Design
An appellate judge on Wednesday reinstated a scaffolding manufacturer's three registered designs for builders' trestles, ruling that its many components all formed a single product rather than several alternative goods.
-
April 02, 2025
Microsoft Sued In Germany Over Video Coding Patents
Three licensors in Via LA's patent pool have sued Microsoft in Germany for allegedly infringing their essential video-coding patents through its sales of Windows and Xbox products, their lawyer said Wednesday.
-
April 02, 2025
Toy Seller Denies Copying Rival's 'Paw Bear' IP
A toy seller has fought back against claims that it copied a teddy bear design to steal customers, arguing that its rival was not the first company to give the stuffed animals a neck bow and rough patches.
-
April 02, 2025
Paddington Bear Owner Sues Souvenir Seller Over Copyright
The owner of Paddington Bear has hit a souvenir wholesaler with a copyright infringement claim in a London court, accusing it of using copies of the iconic bear on products without its permission.
-
April 01, 2025
AstraZeneca Keeps Generics Off Shelves Ahead Of Appeal
Counsel for AstraZeneca convinced the Court of Appeal on Monday to review a decision to let rival Glenmark release its generic version of a billion-dollar diabetes treatment under an agreement that the company can ship supplies of the drug already packed in trucks as long as it doesn't move ahead with retail sales in the meantime.
-
April 01, 2025
BAT Unit Can't Nix Philip Morris E-Cig Patent On Appeal
Philip Morris has retained its patent for a method of heating electronic cigarettes, with European officials tossing a challenge from a British American Tobacco unit after finding that Philip Morris' amended claims made the invention new.
-
April 01, 2025
Pfizer, Merck Lose Appeal To Patent Cancer Drug Dosage
European officials have rejected Pfizer and Merck's second bid to patent a specific cancer drug dosage, ruling that the pharmaceutical giants didn't provide any new justification to protect the treatment they developed together.
-
April 01, 2025
Nestlé's Smarties Brand Beats Low-Sugar 'Smart Sweets' TM
Nestlé has beaten a Canadian low-sugar candy maker's bid for a "Smart Sweets" trademark after European officials were persuaded that confectionery lovers were likely to confuse the brand with the multicolored chocolate Smarties.
-
April 01, 2025
Fire Alarm Patent Not New, Electrical Supplier Argues
An electrical equipment supplier has told a London court that a rival fire alarm manufacturer's patent for fire and carbon monoxide alarm systems is not viable because the supplier's competitor sold similar alarm systems before the patent was filed.
-
April 01, 2025
Hydrogen Tech Biz Must Hand IP To Inventor In Dutch Row
An inventor has persuaded a court in the Netherlands to order an energy company to hand over a group of applications for patents to extract hydrogen from water after concluding that he is the rightful owner.
-
April 01, 2025
Candey Denies Mishandling Client's Funds In Libel Dispute
Disputes firm Candey Ltd. has denied a claim by a former client that it mishandled her money following a settlement in a trademark dispute, while pressing home its allegation that her one-star Google review of its performance was defamatory.
-
March 31, 2025
Novartis, Genentech Lose Asthma Drug Patent In Netherlands
Celltrion Inc. has persuaded a Dutch court to revoke Novartis and Genentech's patent in the Netherlands for asthma drug omalizumab, straying from a London judge's recent decision to uphold the U.K. part of the patent.
-
March 31, 2025
Boult Wade Atty Named Chief Of IP Group's UK Arm
A European intellectual property union has named a Boult Wade Tennant LLP partner as the new president of its British group.
-
March 31, 2025
Adidas Refused Broader Protection For Sports Shoe Patent
European patent officials have rejected a bid by Adidas AG for a broader version of a patent for one of its sports shoe designs but disagreed with a Swiss competitor that the patent should be scrapped entirely.
-
March 31, 2025
Session Musicians Need Streaming Revenue Fix, Union Says
The Musicians' Union has pushed the government to give session musicians a share of streaming royalties, noting that a recent increase in upfront studio fees wasn't enough to balance the scales given the streaming industry's gains.
-
March 31, 2025
LVMH Units Win Glenmorangie, Belvedere Counterfeits Claim
Two LVMH-owned companies behind Scotch whisky brand Glenmorangie and Polish vodka Belvedere have convinced a court in the Netherlands that a Chinese company infringed their trademarks by importing and storing thousands of counterfeit bottles.
-
March 31, 2025
Nokia, Amazon End Long-Running Patent Feud With License
Nokia said Monday that it has inked a patent agreement with Amazon to cover its video technology, marking the end of litigation between the two companies across several continents.
-
March 28, 2025
Patent Court Likely To Lure Patent Holders With UK IP In Play
The Unified Patent Court has now doubled down on its authority to hear claims involving U.K. patents, a move that is likely to make the court an even more desirable forum for global infringement actions.
-
March 28, 2025
VistaJet Escapes VC Fund's Claim Over Investment Deal
A private jet company owner escaped allegations from a Guernsey venture capital fund that he secretly set up companies to leverage the resources of a business it had invested in, when a London court ruled Friday that the claim came too late.
-
March 28, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen sparkling winemaker Nyetimber hit a rival distillery with an intellectual property claim, Newcastle United's former owner Mike Ashley target the club's ex-vice president for damages tied to a fraudulent investment, and a real estate agency file a legal claim against law firm Winston & Strawn LLP. Here, Law360 looks at these and other new claims in the U.K.
-
March 28, 2025
CureVac RNA Vax Patent Survives BioNTech's EU Challenge
CureVac SE has fended off a challenge from BioNTech SE of its mRNA therapy patent at a European patent authority, paving the way for CureVac to forge ahead with litigation in the companies' home country of Germany accusing BioNTech of infringing its invention.
-
March 28, 2025
Pharma Co. Sues Ex-VP For Trade Theft To Benefit Rival
A pharma company has sued its former senior vice president, accusing him of secretly downloading confidential information in order to share it with a rival weeks before he resigned.
-
March 28, 2025
MSD Loses Appeal Over Ruling It Broke 'Merck' Branding Ban
A London appeals court upheld on Friday a ruling that U.S.-based Merck Sharp & Dohme LLC breached a court order blocking its use of the name "Merck" in a move to safeguard German rival Merck KGaA's trademark rights.
Expert Analysis
-
Aldi Design Infringement Case Highlights Assessment Issues
The forthcoming English Court of Appeal decision in Marks and Spencer v. Aldi, regarding the alleged infringement of design rights, could provide practitioners with new guidance, particularly in relation to the relevant date for assessment of infringement and the weight that should be attributed to certain design elements in making this assessment, say Rory Graham and Georgia Davis at RPC.
-
Generative AI Raises IP, Data Protection And Contracts Issues
As the EU's recent agreement on the Artificial Intelligence Act has fueled businesses' interest in adopting generative AI tools, it is crucial to understand how these tools utilize material to generate output and what questions to ask in relation to intellectual property, data privacy and contracts, say lawyers at Deloitte Legal.
-
Vodafone Decision Highlights Wide Scope Of UK's FDI Rules
The U.K. government’s recently imposed conditions required for its approval of Vodafone and Etisalat’s strategic relationship agreement under its National Security and Investment Act jurisdiction, illustrating the significance of the act as an important factor for transactions with a U.K. link, says Matthew Hall at McGuireWoods.
-
What The EU AI Act Could Mean For Patent Law
As the EU Artificial Intelligence Act has now been endorsed by all member states, companies and patent owners with interests in the bloc may want to prepare for when the act enters into force, including by considering potential subject matter exclusions, says Terence Broderick at Murgitroyd.
-
Considering A Practical FRAND Rate Assessment Procedure
As the debate over a fair, reasonable and nondiscriminatory rate continues inside and outside courtrooms, a practical method may assess whether the proposed FRAND rate deviates significantly from what is reasonable, and ensure an optimal mix of assets for managers of standard-essential patent portfolios, says consultant Gordon Huang.
-
How AI Inventorship Is Evolving In The UK, EU And US
While the U.K. Supreme Court's recent decision in Thaler v. Comptroller-General is the latest in a series of decisions by U.K., U.S. and EU authorities that artificial intelligence systems cannot be named as inventors in patents, the guidance from these jurisdictions suggests that patents may be granted to human inventors that use AI as a sophisticated tool, say lawyers at Mayer Brown.
-
Cos. Should Plan Now For Extensive EU Data Act Obligations
The recently enacted EU Data Act imposes wide-ranging requirements across industries and enterprises of all sizes, and with less than 20 months until the provisions begin to apply, businesses planning compliance will need to incorporate significant product changes and revision of contract terms, say Nick Banasevic, Robert Spano and Ciara O'Gara at Gibson Dunn.
-
UK Ruling Revitalizes Discussions On Harmonizing AI And IP
The U.K. Supreme Court's decision in Thaler v. Comptroller-General last month has reinvigorated ongoing discussions about how the developments in artificial intelligence fit within the existing intellectual property legislative landscape, illustrating that effective regulation will be critical as the value and influence of this sector grows, say Nick White and Olivia Gray at Charles Russell.
-
AI Inventorship Patent Options After UK Supreme Court Ruling
The U.K. Supreme Court's recent ruling in Thaler v. Comptroller-General of Patents, Designs and Trade Marks that an AI system cannot be an inventor raises questions about alternative approaches to patent protection for AI-generated inventions and how the decision might affect infringement and validity disputes around such patents, says David Knight at Brown Rudnick.
-
Acquisition Of AI Tech Poses Challenges For Media Industry
The artificial intelligence regulatory landscape is changing quickly, and media and entertainment companies planning to acquire AI technology through a merger, acquisition or licensing deal should be mindful of potential new compliance requirements and AI-specific insurance products, say lawyers at Covington.
-
Cos. Should Weave Metaverse Considerations Into IP Strategy
In light of the increasing importance of intellectual property protection in digital contexts, including a growing number of court rulings and recent updates to the classification of digital assets, companies should include the metaverse as part of their trademark strategy to prevent potential infringements, says Gabriele Engels at D Young & Co.
-
Mitigating Compliance And Litigation Risks Of Evolving Tech
Amid artificial intelligence and other technological advances, companies must prepare for the associated risks, including a growing suite of privacy regulations, enterprising class action theories and consumer protection challenges, and proliferating disclosure obligations, say attorneys at Eversheds Sutherland.
-
Major EU AI Banking Ruling Will Reverberate Across Sectors
Following the European Court of Justice's recent OQ v. Land Hessen decision that banks' use of AI-driven credit scores to make consumer decisions did not comply with the General Data Protection Regulation, regulators indicated that the ruling would apply broadly, leaving numerous industries that employ AI-powered decisions open to scrutiny, say lawyers at Alston & Bird.
-
English Could Be The Future Language Of The UPC
While most Unified Patent Court proceedings are currently held in German, the recent decisions in Plant-e v. Arkyne and Amgen v. Sanofi potentially signal that English will be the preferred language, particularly in cases involving small and medium enterprises, say lawyers at Freshfields.
-
Arbitration Remains Attractive For Digital Disputes In 2024
Recent regulatory and digital forum developments highlight that, in 2024, arbitration will continue to adapt to new technologies, such as artificial intelligence and cryptocurrency, and remain an attractive forum for resolving digital disputes due to its flexibility, confidentiality and comparative ease to enforce cross-border awards, says Peter Smith at Charles Russell.